Efficacy and Safety of Semaglutide Versus Canagliflozin as add-on to Metformin in Subjects With Type 2 Diabetes
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT03136484. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial is conducted in Africa, Asia, Europe, North and South America. The aim of the trial is to compare the effect of once-weekly (OW) dosing of subcutaneous semaglutide (1.0 mg) versus once-daily dosing of oral canagliflozin (300 mg) on glycaemic control in subjects with type 2 diabetes (T2D) on a background treatment of metformin
Study identification
- NCT ID
- NCT03136484
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 788 participants
Conditions and interventions
Conditions
Interventions
- Semaglutide Drug
- Canagliflozin Drug
- Placebo (canagliflozin) Drug
- Placebo (semaglutide) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 15, 2017 (Actual)
- Primary completion
- Oct 16, 2018 (Actual)
- Completion
- Nov 16, 2018 (Actual)
- Last update posted
- Jan 21, 2020
2017 – 2018
United States locations
- U.S. sites
- 57
- U.S. states
- 19
- U.S. cities
- 46
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novo Nordisk Investigational Site | Anaheim | California | 92801 | — |
| Novo Nordisk Investigational Site | La Mesa | California | 91942 | — |
| Novo Nordisk Investigational Site | Los Angeles | California | 90057 | — |
| Novo Nordisk Investigational Site | Montclair | California | 91763 | — |
| Novo Nordisk Investigational Site | San Diego | California | 92111 | — |
| Novo Nordisk Investigational Site | Spring Valley | California | 91978 | — |
| Novo Nordisk Investigational Site | Tustin | California | 92780 | — |
| Novo Nordisk Investigational Site | Walnut Creek | California | 94598 | — |
| Novo Nordisk Investigational Site | Fleming Island | Florida | 32003 | — |
| Novo Nordisk Investigational Site | Hallandale | Florida | 33009 | — |
| Novo Nordisk Investigational Site | Hialeah | Florida | 33012 | — |
| Novo Nordisk Investigational Site | Miami | Florida | 33135 | — |
| Novo Nordisk Investigational Site | Miami | Florida | 33155 | — |
| Novo Nordisk Investigational Site | Miami | Florida | 33174 | — |
| Novo Nordisk Investigational Site | Miami | Florida | 33175 | — |
| Novo Nordisk Investigational Site | Miami | Florida | 33186 | — |
| Novo Nordisk Investigational Site | Spring Hill | Florida | 34609 | — |
| Novo Nordisk Investigational Site | Conyers | Georgia | 30094-5965 | — |
| Novo Nordisk Investigational Site | Marietta | Georgia | 30060 | — |
| Novo Nordisk Investigational Site | Meridian | Idaho | 83646 | — |
| Novo Nordisk Investigational Site | Council Bluffs | Iowa | 51501 | — |
| Novo Nordisk Investigational Site | Lexington | Kentucky | 40503 | — |
| Novo Nordisk Investigational Site | Lake Charles | Louisiana | 70601 | — |
| Novo Nordisk Investigational Site | Metairie | Louisiana | 70002 | — |
| Novo Nordisk Investigational Site | Baltimore | Maryland | 21239 | — |
| Novo Nordisk Investigational Site | Hyattsville | Maryland | 20782 | — |
| Novo Nordisk Investigational Site | Detroit | Michigan | 48202 | — |
| Novo Nordisk Investigational Site | Flint | Michigan | 48504 | — |
| Novo Nordisk Investigational Site | Flint | Michigan | 48532 | — |
| Novo Nordisk Investigational Site | Sterling Heights | Michigan | 48310-3503 | — |
| Novo Nordisk Investigational Site | Troy | Michigan | 48098 | — |
| Novo Nordisk Investigational Site | Trenton | New Jersey | 08611 | — |
| Novo Nordisk Investigational Site | Brooklyn | New York | 11229 | — |
| Novo Nordisk Investigational Site | New Windsor | New York | 12553 | — |
| Novo Nordisk Investigational Site | Greensboro | North Carolina | 27408 | — |
| Novo Nordisk Investigational Site | Cincinnati | Ohio | 45212 | — |
| Novo Nordisk Investigational Site | Maumee | Ohio | 43537 | — |
| Novo Nordisk Investigational Site | Toledo | Ohio | 43614 | — |
| Novo Nordisk Investigational Site | Toledo | Ohio | 43623 | — |
| Novo Nordisk Investigational Site | Corvallis | Oregon | 97330-3737 | — |
| Novo Nordisk Investigational Site | Anderson | South Carolina | 29621 | — |
| Novo Nordisk Investigational Site | Amarillo | Texas | 79106 | — |
| Novo Nordisk Investigational Site | Corpus Christi | Texas | 78404 | — |
| Novo Nordisk Investigational Site | Corpus Christi | Texas | 78413 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75230 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75251 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75390-9302 | — |
| Novo Nordisk Investigational Site | Houston | Texas | 77058 | — |
| Novo Nordisk Investigational Site | Houston | Texas | 77074 | — |
| Novo Nordisk Investigational Site | Houston | Texas | 77081 | — |
| Novo Nordisk Investigational Site | Katy | Texas | 77450 | — |
| Novo Nordisk Investigational Site | San Antonio | Texas | 78230 | — |
| Novo Nordisk Investigational Site | Splendora | Texas | 77372 | — |
| Novo Nordisk Investigational Site | St. George | Utah | 84790 | — |
| Novo Nordisk Investigational Site | Herndon | Virginia | 20171 | — |
| Novo Nordisk Investigational Site | Olympia | Washington | 98502 | — |
| Novo Nordisk Investigational Site | Wenatchee | Washington | 98801-2028 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 62 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03136484, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 21, 2020 · Synced Nov 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.